Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebivolol versus atenolol for endothelial function in essential hypertension
2008-007516-15Phase 4Active
- Sponsor
- Negma Group
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of nebivolol and atenolol in essential hypertension (2 arms), sponsored by Negma Group. Primary endpoint: Change in shear stress-diameter relationship of the brachial artery. Started Mar 2009; status: active.
02
Drugs
nebivololatenolol
03
Conditions
essential hypertension
Beyond the preview
Go deeper on 2008-007516-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007516-15.